Table 2.

Weight of patients with MPS II undergoing therapy.

	HSCT (kg)		t-Test to untreated group		ERT (kg)		t-Test to untreated group		t-Test between two treatment groups
Age (years)	n	Mean	SD	p	n	Mean	SD	p	p
9.5 months					1	8.56
1 y					1	9.04
1.5 y					4	12.45	1.33	0.29
2 y	1	18.00			4	15.05	1.34	0.64
3 y	1	17.50			5	18.53	2.08	0.68
4 y	5	21.10	2.79	0.27	6	20.94	1.48	0.08	0.91
5 y	8	23.84	3.83	0.19	5	23.63	2.03	0.12	0.90
6 y	12	26.35	6.42	0.39	8	24.51	3.76	1.00	0.43
8 y	10	30.36	7.45	0.53	11	26.68	2.41	0.39	0.16
10 y	9	35.04	9.72	0.07	7	31.70	5.13	0.15	0.39
12 y	9	38.13	8.50	0.02	7	39.41	9.61	0.04	0.79
14 y	6	42.12	8.01	0.02	1	43.30	–	–
16 y	4	43.13	5.07	0.03
18 y	2	38.00	–	–